Insider trading

Period: 120 months Stock: ZLAB + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

168 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

168 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

168 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

168 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
168 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
168 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

168 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Apr 2024
Amado Rafael See Remarks
Sold at will
$30.59K 1,952 at 15.67
7.7%
Not planned
4 Apr 2024
Edmondson Frazor Titus III Chief Legal Officer
Sold at will
$19.50K 1,244 at 15.67
4.5%
Not planned
4 Apr 2024
Chen Yajing Chief Financial Officer
Sold at will
$13.24K 845 at 15.67
8.1%
Not planned
2 Apr 2024
Du Ying Chairperson & CEO
Sold at will 2×
$93.47K 5,787 at 16.15
0.5%
Not planned
2 Apr 2024
Reinhart Harald See Remarks
Sold at will 2×
$28.64K 1,773 at 16.15
3.5%
Not planned
2 Apr 2024
Edmondson Frazor Titus III Chief Legal Officer
Sold at will 2×
$14.29K 885 at 16.15
3.8%
Not planned
2 Apr 2024
Chen Yajing Chief Financial Officer
Sold at will
$8.38K 519 at 16.15
6.1%
Not planned
15 Mar 2024
Edmondson Frazor Titus III Chief Legal Officer
Sold on a plan
$187.13K 10,000 at 18.71
33.3%
Planned (10b5-1)
15 Mar 2024
Amado Rafael See Remarks
Sold on a plan
$47.98K 2,544 at 18.86
11.2%
Planned (10b5-1)
1 Mar 2024
Smiley Joshua L See Remarks
Bought on a plan
$62.49K 3,000 at 20.83
14.6%
Bought on a plan
3 Jan 2024
Du Ying Chairperson & CEO
Sold at will
$218.90K 8,380 at 26.12
0.7%
Not planned
3 Jan 2024
Reinhart Harald See Remarks
Sold at will
$125.46K 4,803 at 26.12
9.4%
Not planned
3 Jan 2024
Edmondson Frazor Titus III Chief Legal Officer
Sold at will
$125.46K 4,803 at 26.12
13.8%
Not planned
2 Jan 2024
Amado Rafael See Remarks
Sold at will
$509.17K 19,363 at 26.30
46.1%
Not planned
14 Dec 2023
Smiley Joshua L See Remarks
Bought on a plan
$119.60K 4,000 at 29.90
24.2%
Bought on a plan
16 Nov 2023
Smiley Joshua L See Remarks
Bought on a plan
$134.65K 5,000 at 26.93
43.4%
Bought on a plan
2 Nov 2023
Chen Yajing Chief Financial Officer
Sold at will
$4.16K 165 at 25.23
2.3%
Not planned
6 Mar 2023
Edmondson Frazor Titus III Chief Legal Officer
Sold, plan not stated
$322.98K 7,965 at 40.55
29.1%
3 Mar 2023
Reinhart Harald See Remarks
Sold, plan not stated
$459.20K 11,480 at 40.00
37.7%
3 Mar 2023
Lis William Director
Sold, plan not stated
$208.18K 5,434 at 38.31
18.9%
8 Dec 2022
WIRTH PETER Director · indirect
Sold, plan not stated
$141.32K 4,000 at 35.33
100%
Sold half or more
8 Dec 2022
WIRTH PETER Director
Sold, plan not stated
$136.25K 3,852 at 35.37
1.1%
15 Nov 2022
Reinhart Harald See Remarks
Sold, plan not stated 2×
$74.16K 1,854 at 40.00
6.9%
4 Feb 2022
DIEKMAN JOHN D Director
Sold, plan not stated
$50.17K 1,000 at 50.17
1.5%
20 Jan 2022
Lis William Director
Sold, plan not stated
$102.85K 1,926 at 53.40
5.3%
8 Dec 2021
WIRTH PETER Director
Bought
$285.44K 4,000 at 71.36
1.2%
First buy on file
5 Nov 2021
DIEKMAN JOHN D Director
Sold, plan not stated
$91.65K 1,000 at 91.65
1.6%
28 Oct 2021
Fu Tao President & COO · indirect
Sold, plan not stated 2×
$1.05M 10,000 at 105.00
11.4%
14 Oct 2021
Fu Tao President & COO · indirect
Sold, plan not stated 3×
$1.03M 10,000 at 102.68
10.3%
30 Sep 2021
Fu Tao President & COO · indirect
Sold, plan not stated 4×
$1.07M 10,000 at 106.73
9.3%
15 Sep 2021
Fu Tao President & COO
Sold, plan not stated 8×
$1.28M 10,000 at 127.92
4.6%
9 Sep 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated 9×
$1.41M 10,000 at 141.36
100%
Sold half or more
7 Sep 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 8×
$4.49M 29,785 at 150.73
2.9%
7 Sep 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated 6×
$1.51M 10,000 at 150.93
100%
Sold half or more
3 Sep 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 4×
$3.50M 24,145 at 145.04
2.3%
2 Sep 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 4×
$4.19M 28,738 at 145.79
2.6%
1 Sep 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 7×
$4.17M 28,443 at 146.46
2.5%
25 Aug 2021
Fu Tao President & COO
Sold, plan not stated 4×
$1.43M 10,000 at 143.03
4.6%
24 Aug 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated
$1.15M 8,000 at 143.36
100%
Sold half or more
23 Aug 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated
$1.08M 8,000 at 135.00
100%
Sold half or more
5 Aug 2021
DIEKMAN JOHN D Director
Sold, plan not stated
$149.50K 1,000 at 149.50
1.6%
3 Aug 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 7×
$3.84M 26,217 at 146.38
2.5%
2 Aug 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 7×
$12.27M 84,894 at 144.56
7.6%
15 Jul 2021
Fu Tao President & COO
Sold, plan not stated 6×
$1.73M 10,000 at 172.82
4.6%
14 Jul 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated 2×
$1.35M 8,000 at 169.11
100%
Sold half or more
13 Jul 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated
$1.36M 8,000 at 169.92
100%
Sold half or more
2 Jul 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 4×
$4.78M 27,253 at 175.31
2.6%
1 Jul 2021
Du Ying Chairwoman & CEO
Sold, plan not stated 6×
$14.73M 83,858 at 175.70
7.5%
17 Jun 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated
$1.29M 8,000 at 161.64
100%
Sold half or more
16 Jun 2021
Reinhart Harald Chief Medical Officer
Sold, plan not stated
$1.30M 8,000 at 162.71
100%
Sold half or more
Showing 101–150 of 168. ← Newer Page 3 of 4 Older →